PET494 Antibody

What is the PET494 gene and what is its primary function?

PET494 is a nuclear gene in Saccharomyces cerevisiae (baker's yeast) that encodes a protein required for the post-transcriptional accumulation of subunit III of cytochrome c oxidase (coxIII). The PET494 protein localizes to mitochondria where it specifically promotes coxIII translation by interacting with the 5'-untranslated leader region of the oxi2 mRNA (which encodes coxIII) . The protein functions as a translational activator that is essential for respiratory competence in yeast cells .

Where is the PET494 gene located in the yeast genome?

The PET494 gene has been mapped to chromosome XIV in the Saccharomyces cerevisiae genome. Genetic mapping studies have positioned it between the rna2 and lys9 loci, approximately 2.4 centimorgans from lys9 . Molecular cloning of the gene identified a 4.4 kb fragment containing the complete PET494 gene, with subsequent subcloning demonstrating that a 2 kb fragment retains the ability to complement pet494 mutations .

How does PET494 interact with mitochondrial gene expression?

PET494 protein functions as a mitochondrial translational activator that specifically targets the translation of the oxi2 mRNA. Research has shown that PET494 interacts with the 5'-untranslated leader of the oxi2 transcript . This interaction is essential for the translation of subunit III of cytochrome c oxidase. Evidence for this mechanism comes from suppressor studies where mutations that suppress pet494 deletions were found to be rearrangements of the mitochondrial oxi2 gene that had acquired 5'-flanking sequences from other mitochondrial genes . These rearrangements allowed the oxi2 transcripts to carry alternative 5'-untranslated leaders, bypassing the need for PET494-mediated translational activation.

What is the molecular structure of the PET494 protein?

While the search results do not provide detailed structural information, the PET494 protein is encoded by a nuclear gene but functions within mitochondria. Research has shown that both unmodified PET494 and PET494-beta-galactosidase fusion proteins are specifically associated with mitochondria . The primary structure of both wild-type and mutant alleles of the PET494 gene has been determined, providing insights into the amino acid sequence of the protein . Further structural studies using X-ray crystallography or cryo-EM would be needed to determine the detailed three-dimensional structure of the protein, which could provide insights into how it interacts with mitochondrial RNA.

What domains or motifs are present in the PET494 protein that enable its RNA binding function?

Based on the available research, PET494 interacts with the 5'-untranslated leader of the oxi2 mRNA . Although the specific RNA-binding domains or motifs are not explicitly detailed in the search results, the protein likely contains structural elements that facilitate RNA recognition and binding. Comparative sequence analysis with other translational activators might reveal conserved domains associated with RNA interaction. Experimental approaches such as domain mapping through truncation analysis, site-directed mutagenesis of conserved residues, and RNA binding assays would be valuable for identifying the specific regions involved in mRNA recognition and translational activation.

What are the best methods for isolating and purifying PET494 protein for in vitro studies?

For isolating and purifying PET494 protein, researchers should consider the following methodological approach:

• Expression System Selection: Given that PET494 is a yeast protein, expression in S. cerevisiae using vectors like pYES2 or pRS series would maintain native folding. Alternatively, E. coli systems with appropriate tags (His, GST, or MBP) can be used for higher yields.

• Mitochondrial Isolation: Since PET494 localizes to mitochondria, isolation of mitochondrial fractions would be necessary when purifying the native protein from yeast. This can be achieved using differential centrifugation methods as described in established protocols .

• Affinity Purification: For tagged recombinant proteins, standard affinity chromatography can be employed. For native PET494, immunoprecipitation using specific antibodies would be effective.

• Size Exclusion Chromatography: This technique can be used as a polishing step to achieve higher purity and to analyze the oligomeric state of the protein.

• Activity Verification: RNA binding assays using the 5'-UTR of oxi2 mRNA should be performed to confirm that the purified protein retains its biological activity.

How can PET494-RNA interactions be studied in vitro?

Several complementary approaches can be employed to study PET494-RNA interactions:

• Electrophoretic Mobility Shift Assays (EMSA): These assays can demonstrate direct binding between purified PET494 and labeled oxi2 mRNA 5'-UTR fragments.

• RNA Footprinting: This technique can identify specific nucleotides in the oxi2 5'-UTR that are protected by PET494 binding, revealing the precise interaction sites.

• Surface Plasmon Resonance (SPR): SPR allows real-time measurement of binding kinetics and affinity between PET494 and various RNA constructs.

• UV Cross-linking: This approach can capture transient interactions and help identify amino acid residues in direct contact with the RNA.

• Fluorescence Anisotropy: This method can measure binding affinities and is particularly useful for analyzing how mutations in either the protein or RNA affect interaction strength.

These methodologies would provide comprehensive insights into the specificity, affinity, and structural basis of PET494-RNA interactions.

How do suppressors of pet494 mutations provide insight into the mechanism of PET494 function?

Suppressor analysis has provided critical insights into PET494 function. When researchers isolated mutations that suppress a pet494 deletion, they found these suppressors were rearrangements of the mitochondrial oxi2 gene . These rearrangements resulted in the oxi2 gene acquiring 5'-flanking sequences from other mitochondrial genes, which led to the production of oxi2 transcripts with alternative 5'-untranslated leaders .

This finding reveals several key aspects of PET494 function:

• Specificity for 5'-UTR: The fact that alternative 5'-UTRs bypass the need for PET494 confirms that the protein specifically interacts with the native oxi2 5'-UTR to promote translation.

• Mechanistic Insights: These suppressors demonstrate that PET494's role is not in the general translation machinery but in sequence-specific recognition of particular mRNAs.

• Evolutionary Implications: The ability of alternative 5'-UTRs to support translation suggests evolutionary plasticity in mitochondrial gene expression mechanisms.

A comparative analysis of suppressor efficiency is presented in the table below:

What is the relationship between PET494 and other mitochondrial translational activators?

PET494 represents one of several nuclear-encoded proteins that act as specific translational activators for mitochondrial mRNAs. While the search results don't explicitly compare PET494 with other activators, similar proteins such as CBP1 and CBP6 have been identified as necessary for the expression of cytochrome b .

The relationships between these translational activators can be characterized by:

• Target Specificity: Different activators target specific mitochondrial mRNAs - PET494 targets the oxi2 transcript (encoding coxIII), while others like CBP1 and CBP6 target the cytochrome b transcript .

• Mechanistic Conservation: These activators likely share similar mechanisms, interacting with the 5'-untranslated regions of their target mRNAs to promote translation.

• Evolutionary Significance: The existence of multiple specific translational activators suggests an evolved regulatory system for fine-tuning the expression of mitochondrial respiratory components.

• Potential Interactions: Though not explicitly shown in the search results, these activators might form regulatory networks or complexes to coordinate mitochondrial gene expression.

Further research using proteomics approaches, co-immunoprecipitation studies, and genetic interaction analyses would help elucidate the functional relationships between PET494 and other translational activators in the context of mitochondrial gene expression regulation.

What strategies can be used to create specific antibodies against PET494?

Developing specific antibodies against PET494 requires careful consideration of several factors:

• Antigen Selection: Based on protein structure prediction, select unique, exposed epitopes of PET494. Both recombinant full-length protein and synthetic peptides corresponding to unique regions can be used as antigens.

• Antibody Production Approaches:

  • Polyclonal Antibodies: Immunize rabbits or goats with purified PET494 or KLH-conjugated peptides for broad epitope recognition.

  • Monoclonal Antibodies: Use mouse hybridoma technology with recombinant PET494 to generate highly specific antibodies.

  • Recombinant Antibodies: Phage display technology can be employed to develop single-chain variable fragments (scFvs) against PET494.

• Validation Strategies:

  • Western blot analysis using wild-type and pet494Δ yeast strains

  • Immunoprecipitation followed by mass spectrometry

  • Immunofluorescence to confirm mitochondrial localization

  • Cross-reactivity testing against related proteins

• Epitope Mapping: Determine the specific binding sites using peptide arrays or hydrogen-deuterium exchange mass spectrometry.

What are the key considerations for designing experiments to study PET494 localization and function?

When designing experiments to study PET494 localization and function, researchers should consider the following methodological approaches:

• Subcellular Localization Studies:

  • Fusion proteins with fluorescent tags (GFP, mCherry)

  • Immunogold electron microscopy for high-resolution localization

  • Cell fractionation followed by western blotting

  • Co-localization with known mitochondrial markers

• Functional Analyses:

  • Gene deletion and complementation studies

  • Site-directed mutagenesis of conserved domains

  • RNA binding assays using wild-type and mutant proteins

  • Polysome profiling to assess translational activity

• Interaction Studies:

  • Yeast two-hybrid or split-ubiquitin assays

  • Co-immunoprecipitation of protein complexes

  • Proximity labeling (BioID, APEX)

  • Crosslinking and mass spectrometry

• Temporal and Condition-Dependent Regulation:

  • Analysis under different carbon sources and oxygen conditions

  • Response to mitochondrial stress

  • Cell-cycle dependent regulation

• Quantitative Assessments:

  • RT-qPCR for transcript levels

  • Western blotting for protein levels

  • Translation efficiency measurements

  • Respiratory capacity assays

What are common difficulties in studying PET494 and how can they be overcome?

Researchers studying PET494 may encounter several challenges:

• Protein Solubility and Stability Issues:

  • Challenge: PET494 may form inclusion bodies when overexpressed.

  • Solution: Use solubility-enhancing tags (MBP, SUMO), optimize expression conditions (lower temperature, reduced induction), or employ in vitro refolding protocols.

• Functional Redundancy:

  • Challenge: Potential overlapping functions with other translational activators.

  • Solution: Create multiple gene deletions, use conditional mutants, or employ synthetic genetic array analysis to identify genetic interactions.

• Post-Translational Modifications:

  • Challenge: Important modifications may be lost in heterologous expression systems.

  • Solution: Use mass spectrometry to identify modifications, create phosphomimetic mutants, or express in yeast to maintain native modifications.

• RNA-Protein Interaction Specificity:

  • Challenge: Distinguishing specific from non-specific RNA binding.

  • Solution: Include appropriate controls (scrambled sequences, competitor RNAs), perform dose-response studies, and validate interactions using multiple methods.

• Mitochondrial Import Efficiency:

  • Challenge: Ensuring efficient targeting to mitochondria in experimental systems.

  • Solution: Verify targeting sequence functionality, use mitochondrial isolation to confirm localization, and employ in organello import assays.

How can contradictory results in PET494 research be reconciled?

When faced with contradictory results in PET494 research, consider the following systematic approach:

• Methodological Differences:

  • Examine variations in experimental procedures, including protein purification methods, buffer conditions, and assay parameters.

  • Consider differences in strain backgrounds, which may contain suppressor mutations.

• Genetic Background Effects:

  • Different yeast strains may harbor genetic modifiers that affect PET494 function.

  • Create isogenic strains by backcrossing or using CRISPR-Cas9 to introduce identical mutations in different backgrounds.

• Environmental Conditions:

  • Yeast growth conditions (carbon source, oxygen availability, temperature) significantly impact mitochondrial function.

  • Standardize growth conditions or systematically test environmental variables.

• Protein Isoforms and Modifications:

  • Alternative splicing or post-translational modifications may create functionally distinct variants.

  • Use techniques like mass spectrometry to characterize protein species in different experimental conditions.

• Indirect vs. Direct Effects:

  • Determine whether phenotypes are directly caused by PET494 or are downstream consequences.

  • Use acute inactivation approaches (degron tags, temperature-sensitive alleles) to distinguish immediate from adaptive effects.

What emerging technologies could advance our understanding of PET494 function?

Several cutting-edge technologies show promise for advancing PET494 research:

• Cryo-EM and AlphaFold Structure Prediction:

  • High-resolution structural analysis of PET494 alone and in complex with target RNAs

  • Integration of experimental data with AI-based structure prediction

• CRISPR-Based Technologies:

  • Prime editing for precise genomic modifications without double-strand breaks

  • CRISPRi/CRISPRa for tunable gene expression modulation

  • Base editors for introducing specific point mutations

• Single-Molecule Approaches:

  • smFRET to analyze conformational changes during RNA binding

  • Optical tweezers to measure binding forces

  • Nanopore sequencing for direct RNA-protein interaction mapping

• Spatial Transcriptomics and Proteomics:

  • Visualizing PET494-mRNA interactions within intact mitochondria

  • Spatial organization of translation complexes using super-resolution microscopy

• Systems Biology Integration:

  • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

  • Network modeling of mitochondrial translation regulation

  • Machine learning to predict functional consequences of PET494 mutations

What are the implications of PET494 research for understanding human mitochondrial diseases?

While PET494 is a yeast protein, research on its function has broader implications for understanding human mitochondrial diseases:

• Translational Activator Homologs:

  • Though direct homologs may not exist in humans, mechanistic insights into translational regulation in mitochondria are relevant across species.

  • Identifying functional equivalents in human mitochondria could provide new disease targets.

• Conservation of Regulatory Mechanisms:

  • The principle of mRNA-specific translational regulation likely extends to human mitochondria.

  • Understanding these mechanisms may explain tissue-specific manifestations of mitochondrial diseases.

• Therapeutic Development:

  • Insights into how suppressors bypass the need for PET494 could inspire therapeutic strategies.

  • Approaches that modify mRNA structures or recruit alternative translational activators might be applicable to human diseases.

• Model Systems for Mitochondrial Translation:

  • Yeast serves as a valuable model for studying principles of mitochondrial translation that are difficult to study directly in human cells.

  • Findings can guide more focused studies in mammalian systems.

• Biotechnological Applications:

  • Engineering translational activators could allow targeted expression of specific mitochondrial genes.

  • Such tools could have applications in both research and therapeutic development.